Focused on medical devices for the treatment of carotid artery disease, the company develops and markets systems used in transcarotid artery revascularization (TCAR), a minimally invasive procedure designed to reduce stroke risk in patients with carotid artery blockages. Its product portfolio includ...
1 member of Congress has disclosed 1 trade in Silk Road Medical, Inc (SILK), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |